However, emapalumab has been reported to be a viable rescue treatment for patients with EBV-HLH.[11] Additionally, Brito-Zeron et al[12] suggested that anti-tumor necrosis factor therapy may be effective. Here, TNF is linked to hemophagocytic syndrome.